| Indicators | Browse All

electroCore, Inc. (ECOR)

Healthcare | Medical Devices | Rockaway, United States | NasdaqCM
8.35 USD +0.15 (1.829%) ⇧ (Oct. 15, 2026, 4 p.m. EDT)

Short-term:★★☆☆☆Long-term:★⯪☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 2:14 a.m. EDT

The immediate outlook is clouded by severe operational distress rather than speculative momentum. Despite a recent surge and a positive revenue beat, the company is bleeding cash aggressively, with both operating and free cash flows deeply negative, while simultaneously posting significant losses on a trailing basis. The balance sheet is fragile, showing negative book value and a current ratio barely above 1.0, suggesting liquidity risks are imminent. While the 200-day moving average offers some technical support, the fundamental reality of burning capital without a clear path to profitability makes a near-term bullish entry highly risky. The statistical forecast model is completely unreliable, offering no guidance on the short-term price noise. Consequently, the short-term rating remains bearish due to the lack of a sustainable earnings engine and deteriorating cash dynamics. Looking further ahead, the investment case is severely compromised by the company's inability to generate profit or return capital to shareholders. The negative earnings per share and return on assets indicate that the core business is destroying value, and the negative enterprise-to-EBITDA multiple reflects this structural impairment. Although revenue growth is positive, it is insufficient to offset the massive operational inefficiencies and cash burn. There is no indication of a turnaround in margins or a restoration of profitability in the visible future. Without a proven track record of generating free cash flow or achieving breakeven, the long-term thesis remains weak, as the company lacks the financial resilience to survive prolonged periods of market stress or funding droughts. The absence of any dividend policy further highlights the company's focus on survival rather than shareholder returns.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.082983
AutoARIMA0.087433
AutoETS0.087434
AutoTheta0.089867

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 31%
H-stat 2.47
Ljung-Box p 0.000
Jarque-Bera p 0.907
Excess Kurtosis -0.31
Attribute Value
Sector Healthcare
Revenue per Share 4.143
Market Cap 75,282,640
Forward P/E -15.18
Beta 1.05
Profit Margins -39.96%
Website https://www.electrocore.com

Info Dump

Attribute Value
52 Week Change 0.700611
Address1 200 Forge Way
Address2 Suite 205
All Time High 303.75
All Time Low 2.925
Ask 8.38
Ask Size 2
Average Daily Volume10 Day 79,180
Average Daily Volume3 Month 83,757
Average Volume 83,757
Average Volume10Days 79,180
Beta 1.054
Bid 8.39
Bid Size 1
Book Value -0.31
City Rockaway
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 8.35
Current Ratio 1.21
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 8.4985
Day Low 7.87
Display Name electroCore
Dividend Yield 0.0
Earnings Call Timestamp End 1,786,046,400
Earnings Call Timestamp Start 1,786,046,400
Earnings Timestamp 1,786,046,400
Earnings Timestamp End 1,793,822,400
Earnings Timestamp Start 1,793,822,400
Ebitda -13,661,000
Ebitda Margins -0.36956
Enterprise To Ebitda -5.476
Enterprise To Revenue 2.024
Enterprise Value 74,801,640
Eps Forward -0.55
Eps Trailing Twelve Months -1.65
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fax 973 290 9171
Fifty Day Average 9.8887
Fifty Day Average Change -1.5386992
Fifty Day Average Change Percent -0.15560177
Fifty Two Week Change Percent 70.0611
Fifty Two Week High 12.7
Fifty Two Week High Change -4.3499994
Fifty Two Week High Change Percent -0.34251964
Fifty Two Week Low 4.41
Fifty Two Week Low Change 3.9400005
Fifty Two Week Low Change Percent 0.8934242
Fifty Two Week Range 4.41 - 12.7
Financial Currency USD
First Trade Date Milliseconds 1,529,674,200,000
Float Shares 5,981,048
Forward Eps -0.55
Forward P E -15.181819
Free Cashflow -4,682,500
Full Exchange Name NasdaqCM
Full Time Employees 83
Fullday Change 0.15000057
Fullday Change Percent 1.8270473
Fullday Price 8.35
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.87056
Gross Profits 32,181,000
Has Pre Post Market Data 1
Held Percent Insiders 0.34187
Held Percent Institutions 0.11927
Implied Shares Outstanding 9,015,885
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Is Earnings Date Estimate 0
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,676,419,200
Last Split Factor 1:15
Long Business Summary electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
Long Name electroCore, Inc.
Market us_market
Market Cap 75,282,640
Market State PRE
Max Age 86,400
Message Board Id finmb_224595724
Most Recent Quarter 1,782,777,600
Net Income To Common -14,770,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 103,051,565
Number Of Analyst Opinions 5
Open 8.13
Operating Cashflow -9,735,000
Operating Margins -0.29333
Phone 888 903 2673
Previous Close 8.2
Price Hint 2
Price To Book -26.935486
Price To Sales Trailing12 Months 2.0365374
Profit Margins -0.39956
Quick Ratio 0.938
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.150001
Regular Market Change Percent 1.82928
Regular Market Day High 8.4985
Regular Market Day Low 7.87
Regular Market Day Range 7.87 - 8.4985
Regular Market Open 8.13
Regular Market Previous Close 8.2
Regular Market Price 8.35
Regular Market Time 1,792,094,401
Regular Market Volume 93,419
Return On Assets -0.54995996
Revenue Growth 0.28
Revenue Per Share 4.143
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 9,015,885
Shares Percent Shares Out 0.0349
Shares Short 314,260
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 325,612
Short Name electroCore, Inc.
Short Percent Of Float 0.0364
Short Ratio 3.69
Source Interval 15
State NJ
Symbol ECOR
Target High Price 26.0
Target Low Price 12.0
Target Mean Price 19.17
Target Median Price 19.85
Total Cash 10,044,000
Total Cash Per Share 1.114
Total Debt 9,563,000
Total Revenue 36,966,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.65
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 7.6075
Two Hundred Day Average Change 0.7425003
Two Hundred Day Average Change Percent 0.09760109
Type Disp Equity
Volume 93,419
Website https://www.electrocore.com
Zip 7,866